VERVE THERAPEUTICS INC
VERVE THERAPEUTICS INC logo
VERV

VERVE THERAPEUTICS INC (VERV)

$21.652.08%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$21.23
Day's Range
$22.45
$10.7
52-Week Range
$43.0
1 month return7.4%
3 month return43.8%
1 year return33.71%
5 year return52.93%

Company Information

Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.
OrganizationVERVE THERAPEUTICS INC
Employees113
CEODr. Sekar Kathiresan M.D.
IndustryHealthcare

Analyst Recommendation

based on 5 analysts ratings

Buy
60%
Buy
40%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for VERVE THERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 125.17%

Current

$21.65

Target

$48.75

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
3
12
11
Hold
2
2
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
1.3B
Book Value
$9.07
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
8.55
PE Ratio
2.53
Wall Street Target Price
48.75

Valuation

Trailing PE2.53
Forward PE0.0
Price/Book (mrq)
2.49
Enterprise Value
891.3M
Enterprise Value/Revenue
959.38
Enterprise Value/Ebitda
-6.02

Technicals

50 Day MA
28.85
200 Day MA
25.25

Institutional Holdings

FMR Inc

8.63%

Vanguard Group Inc

5.94%

ARK Investment Management LLC

5.51%

BlackRock Inc

5.48%

Casdin Capital, LLC

5.16%

State Street Corporation

4.54%

Discover more

Frequently Asked Questions

What is VERVE THERAPEUTICS INC share price today?

Can Indians buy VERVE THERAPEUTICS INC shares?

How can I buy VERVE THERAPEUTICS INC shares from India?

Can Fractional shares of VERVE THERAPEUTICS INC be purchased?

What are the documents required to start investing in VERVE THERAPEUTICS INC stocks?

What are today’s High and Low prices of VERVE THERAPEUTICS INC?

What are today’s traded volumes of VERVE THERAPEUTICS INC?

What is today’s market capitalisation of VERVE THERAPEUTICS INC?

What is the 52 Week High and Low Range of VERVE THERAPEUTICS INC?

How much percentage VERVE THERAPEUTICS INC is down from its 52 Week High?

How much percentage VERVE THERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of VERVE THERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of VERVE THERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*